256 filings
Page 2 of 13
8-K
5f5lk7on794di 76j
13 Nov 23
Cara Therapeutics Reports Third Quarter 2023 Financial Results
4:11pm
8-K
5b5585jvvtn9 2oiar36
2 Nov 23
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
7:10am
8-K
qu45 k0wpz873c9
7 Aug 23
Corporate Presentation August 2023
4:24pm
8-K
tiozg
7 Aug 23
Cara Therapeutics Reports Second Quarter 2023 Financial Results
4:10pm
8-K
ksxvvph
3 Aug 23
Cara Therapeutics Appoints Helen M. Boudreau to
7:06am
8-K
dq1gvq5sra8u92dpws6y
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
9niurluu5d
15 May 23
Corporate Presentation May 2023
4:21pm
8-K
gzcuk 9hcbi
15 May 23
Cara Therapeutics Reports First Quarter 2023 Financial Results
4:10pm
ARS
zodpc7 hnnuq
20 Apr 23
Annual report to shareholders
4:28pm
DEFA14A
33qjgy 9grluwi2
20 Apr 23
Additional proxy soliciting materials
4:24pm
8-K
2mze8ihg
23 Mar 23
Corporate Presentation March 2023
5:04pm
8-K
ddig7e
10 Mar 23
Regulation FD Disclosure
5:03pm
S-8
pynau8wlnwuhm5v3
6 Mar 23
Registration of securities for employees
4:44pm
8-K
tyeesb885m8kfq
6 Mar 23
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
4:10pm
8-K
ylr s433gespv
9 Jan 23
Regulation FD Disclosure
7:00am